$284.25 Million in Sales Expected for Milacron Holdings Corp (NYSE:MCRN) This Quarter

Analysts expect that Milacron Holdings Corp (NYSE:MCRN) will post sales of $284.25 million for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Milacron’s earnings, with estimates ranging from $275.80 million to $299.34 million. Milacron reported sales of $328.10 million in the same quarter last year, which would suggest a negative year over year growth rate of 13.4%. The firm is scheduled to issue its next quarterly earnings results on Thursday, July 25th.

According to Zacks, analysts expect that Milacron will report full year sales of $1.12 billion for the current financial year. For the next fiscal year, analysts expect that the firm will report sales of $1.15 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Milacron.

Milacron (NYSE:MCRN) last announced its quarterly earnings results on Tuesday, April 30th. The industrial products company reported $0.27 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.01. Milacron had a negative return on equity of 74.38% and a net margin of 2.91%. The company had revenue of $248.70 million for the quarter, compared to the consensus estimate of $279.52 million. During the same period last year, the firm earned $0.40 EPS. The firm’s revenue for the quarter was down 13.9% compared to the same quarter last year.

Several equities analysts have issued reports on the company. ValuEngine raised Milacron from a “strong sell” rating to a “sell” rating in a research note on Friday, April 19th. Zacks Investment Research downgraded Milacron from a “hold” rating to a “strong sell” rating in a report on Monday, March 11th.

NYSE:MCRN opened at $13.80 on Friday. Milacron has a 52 week low of $11.11 and a 52 week high of $22.09. The firm has a market cap of $910.88 million, a PE ratio of 7.75, a PEG ratio of 2.01 and a beta of 1.67. The company’s 50-day simple moving average is $12.79.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MCRN. Advisory Services Network LLC increased its holdings in shares of Milacron by 998.8% during the fourth quarter. Advisory Services Network LLC now owns 4,395 shares of the industrial products company’s stock valued at $52,000 after acquiring an additional 3,995 shares in the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of Milacron by 22.4% during the first quarter. Oppenheimer Asset Management Inc. now owns 6,275 shares of the industrial products company’s stock valued at $71,000 after buying an additional 1,147 shares during the last quarter. Great West Life Assurance Co. Can grew its stake in shares of Milacron by 77.8% during the fourth quarter. Great West Life Assurance Co. Can now owns 8,713 shares of the industrial products company’s stock valued at $100,000 after buying an additional 3,813 shares during the last quarter. Globeflex Capital L P bought a new position in shares of Milacron during the first quarter valued at approximately $117,000. Finally, Diamond Hill Capital Management Inc. bought a new position in shares of Milacron during the fourth quarter valued at approximately $121,000.

Milacron Company Profile

Milacron Holdings Corp. manufactures, distributes, and services engineered and customized systems within the plastic technology and processing industry in the United States and internationally. The company operates through three segments: Advanced Plastic Processing Technologies (APPT), Melt Delivery and Control Systems (MDCS), and Fluid Technologies (Fluids).

Featured Article: What is Forex?

Get a free copy of the Zacks research report on Milacron (MCRN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Milacron (NYSE:MCRN)

Receive News & Ratings for Milacron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milacron and related companies with MarketBeat.com's FREE daily email newsletter.